Related Experiment Video
Updated: Feb 2, 2026

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
Klotho Deficiency Accelerates Stem Cells Aging by Impairing Telomerase Activity
Mujib Ullah1,2, Zhongjie Sun1,3
1Department of Physiology, College of Medicine, University of Oklahoma Health Sciences Center, Biomedical Research Center, Oklahoma City.
Abstract:
Understanding the effect of molecular pathways involved in the age-dependent deterioration of stem cell function is critical for developing new therapies. The overexpression of Klotho (KL), an antiaging protein, causes treated animal models to enjoy extended life spans. Now, the question stands: Does KL deficiency accelerate stem cell aging and telomere shortening? If so, what are the specific mechanisms by which it does this, and is cycloastragenol (CAG) treatment enough to restore telomerase activity in aged stem cells? We found that KL deficiency diminished telomerase activity by altering the expression of TERF1 and TERT, causing impaired differentiation potential, pluripotency, cellular senescence, and apoptosis in stem cells. Telomerase activity decreased with KL-siRNA knockdown. This suggests that both KL and telomeres regulate the stem cell aging process through telomerase subunits TERF1, POT1, and TERT using the TGFβ, Insulin, and Wnt signaling. These pathways can rejuvenate stem cell populations in a CD90-dependent mechanism. Stem cell dysfunctions were largely provoked by KL deficiency and telomere shortening, owing to altered expression of TERF1, TGFβ1, CD90, POT1, TERT, and basic fibroblast growth factor (bFGF). The CAG treatment partially rescued telomerase deterioration, suggesting that KL plays a critical role in life-extension by regulating telomere length and telomerase activity.
Insights
Klotho deficiency accelerates stem cell aging by impairing telomerase activity and telomere length. Cycloastragenol partially restored telomerase, indicating Klotho
Area of Science:
- Gerontology and Stem Cell Biology
- Molecular Mechanisms of Aging
Background:
- Aging involves stem cell functional decline.
- Klotho (KL) is an antiaging protein linked to extended lifespan.
- The role of KL deficiency in stem cell aging requires elucidation.
Purpose of the Study:
- To investigate if Klotho deficiency accelerates stem cell aging and telomere shortening.
- To identify mechanisms linking KL deficiency to stem cell dysfunction.
- To assess cycloastragenol's efficacy in restoring telomerase activity in aged stem cells.
Main Methods:
- Klotho knockdown using siRNA.
- Assessment of telomerase activity, differentiation potential, pluripotency, senescence, and apoptosis.
- Analysis of gene expression (TERF1, TERT, POT1, TGFβ1, CD90, bFGF).
- Evaluation of cycloastragenol treatment effects.
Main Results:
- Klotho deficiency diminished telomerase activity and altered TERF1 and TERT expression.
- KL deficiency impaired stem cell differentiation, pluripotency, and induced senescence and apoptosis.
- Telomerase activity decreased with KL knockdown.
- Cycloastragenol partially rescued telomerase deterioration.
Conclusions:
- Klotho deficiency accelerates stem cell aging via reduced telomerase activity and telomere shortening.
- KL and telomeres regulate stem cell aging through TERF1, POT1, and TERT, influenced by TGFβ, Insulin, and Wnt signaling.
- KL plays a critical role in life extension by regulating telomere length and telomerase activity.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Adult Stem Cells
Accelerators
The effectiveness of calcium chloride can...
Embryonic Stem Cells
Induced Pluripotent Stem Cells

